13F Filings for Altium Capital Management LLC (CIK: 1746382)

View the most recent portfolio holdings disclosed by this institutional investor in their 13F filing.

HoldingSharesValueChange StatusChange Amount
ZVRA - ZEVRA THERAPEUTICS INC(Class: COM NEW)1.29M $9.64M Decreased562.67K (30.0%, $5.79M)
ALNY - ALNYLAM PHARMACEUTICALS INC(Class: COM)25K* $6.75M* New25K ($6.75M)
EOLS - EVOLUS INC(Class: COM)296.19K $3.56M Decreased388.81K (56.0%, $4M)
XTNT - XTANT MED HLDGS INC(Class: COM NEW)7.25M $3.41M Decreased162.41K (2.0%, $123.88K)
AVDL - AVADEL PHARMACEUTICALS PLC(Class: COM SHS)419.13K $3.28M Decreased33.34K (7.0%, $1.47M)
XENE - XENON PHARMACEUTICALS INC(Class: COM)69.65K* $2.34M* Decreased227.75K (76.0%, $9.32M)
CTNM - CONTINEUM THERAPEUTICS INC(Class: CL A)303.86K $2.12M Decreased30.14K (9.0%, $2.77M)
PROF - PROFOUND MED CORP(Class: COM NEW)360.59K $2.10M Decreased124.41K (25.0%, $1.54M)
EPIX - ESSA PHARMA INC(Class: COM NEW)1.05M $1.66M Decreased377.63K (26.0%, $896.54K)
SKYE - SKYE BIOSCIENCE INC(Class: COM NEW)904.87K $1.44M Decreased234.13K (20.0%, $1.78M)